WALTHAM, Mass.--(BUSINESS WIRE)--Phase Forward Incorporated (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced that it has completed the previously announced executive transition in which Christopher Menard, formerly vice president of finance, has succeeded Rodger Weismann as senior vice president and chief financial officer.
